BlackRock, Inc. 13D and 13G filings for Intellia Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Intellia Therapeutics, Inc. NTLA | BlackRock Inc. BLK | 8,453,014 8.200% | -557,681 (-6.19%) | Filing |
| 2024-01-08 4:35 pm Purchase | 2023-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | BlackRock Inc. BLK | 9,010,695 10.100% | 1,755,774 (+24.20%) | Filing |
| 2023-01-25 10:36 am Purchase | 2022-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | BlackRock Inc. BLK | 7,254,921 8.700% | 1,634,545 (+29.08%) | Filing |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | BlackRock Inc. BLK | 5,620,376 7.600% | 567,531 (+11.23%) | Filing |